Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UMBRA Global is a private U.S. healthcare technology company focused on digital solutions for life and health sciences. Publicly available descriptions position the company as a Health IT business rather than a therapeutics developer, offering software and data-driven products intended to improve care management, interoperability, and health outcomes. The company appears to have developed the Invaryant interoperable data platform and has been associated with HOPE-CAT, a maternal health-focused technology. Available evidence suggests it operates commercially in healthcare services and software, with no clearly disclosed drug-development pipeline or clinical-stage therapeutic assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UMBRA Global.